Flow Pharma

Flow Pharma Overview

Founded 2002
Founded
Status Private
Latest Deal Type Grant
Investors 9

Flow Pharma General Information

Description

Developer of vaccine development platform intended to design synthetic, neoantigen based, Immuno-Oncology therapeutics. The company's platform uses artificial intelligence and deep learning to select small peptides called neoantigens on the surface of cancer cells optimal for killer T-cell attack identified by gene sequencing a patient's cancer cells, enabling patients with vaccines to treat their cancer disease.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 3451 Vincent Road
  • Pleasant Hill, CA 94523
  • United States
+1 (925) 000-0000

Flow Pharma Timeline

2017201820192020
Financing Round
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Flow Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Grant 09-Oct-2018 00.000 Completed Product Development
5. Later Stage VC 28-Feb-2018 00.000 00.000 Completed Startup
4. Angel (individual) 28-Feb-2018 00.000 00.000 Completed Startup
3. Accelerator/Incubator Completed Startup
2. Grant Completed Startup
1. Angel (individual) Completed Startup

Flow Pharma Executive Team (4)

Name Title Board Seat Contact Info
Reid Rubsamen MD Founder, Board Member & Chief Executive Officer
Michael Heatherman Chief Financial Officer
CV Herst Ph.D Chief Scientific Officer
Thomas Brady Vice President of Business Development & Executive Chairman

Flow Pharma Board Members (7)

To view Flow Pharma‘s full board member team, request access >>
Name Representing Role Since
Jack Lloyd Flow Pharma Chairman 000 0000
Pamela Steele Flow Pharma Board Member 000 0000
Reid Rubsamen MD Flow Pharma Founder, Board Member & Chief Executive Officer 000 0000
Stephen Farr Ph.D Self Board Member 000 0000
Thomas Brady Flow Pharma Vice President of Business Development & Executive Chairman 000 0000

1 Former Board Member

Flow Pharma Investors (9)

To view Flow Pharma‘s full investor history, request access >>
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Small Business Innovation Research Government 000 0000 000000 0
Small Business Technology Transfer Program Corporation 000 0000 000000 0
Button Capital Venture Capital Minority 000 0000 000000 0
Agility Labs Accelerator/Incubator Minority 000 0000 000000 0
Naveen Jain Angel (individual) Minority 000 0000 000000 0

Ready to get started?

Request a free trial